Advancements in Alzheimers disease Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease F. Hoffmann-La Roche Ltd - June 16, 2022 • June 16, 2022 View Content